Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566462 · ClinicalTrials.gov registry record · Phase 2
Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
A Phase 2 study, sponsored by Eisai.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00566462 is a Phase 2 study that was terminated before completion, run by Eisai. The registered enrollment target is 1 participants.
The verdict
NCT00566462, a Phase 2 study, was terminated before completion, sponsored by Eisai.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a two-arm, double-blind, placebo-controlled study.
Interventions
- DRUG placebo
- DRUG perampanel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-12-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00566462
The ClinicalTrials.gov registry entry for NCT00566462 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00566462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00566462 about?
NCT00566462 is a clinical study titled "Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT". This is a two-arm, double-blind, placebo-controlled study.
What is the current status of trial NCT00566462?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2007-10. Estimated completion is 2008-12-01.
What interventions are being tested in trial NCT00566462?
The interventions under investigation include: placebo (DRUG), perampanel (DRUG).
Who is sponsoring clinical trial NCT00566462?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.